Marta Weinstock Selected Research

indoline

1/2023	AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell line.
1/2020	A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities.
10/2018	Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents.
1/2017	Cholinergic Anti-Inflammatory Pathway Does Not Contribute to Prevention of Ulcerative Colitis by Novel Indoline Carbamates.
12/2016	Novel indoline derivatives prevent inflammation and ulceration in dinitro-benzene sulfonic acid-induced colitis in rats.
5/2014	Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Weinstock Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 03/2002
6	Inflammation (Inflammations) 06/2023 - 10/2008
3	Dementia (Dementias) 10/2019 - 03/2002
3	Colitis 12/2016 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 05/2014
2	Liver Diseases (Liver Disease) 01/2023 - 10/2021
2	Cognitive Dysfunction 10/2019 - 06/2012
2	Body Weight (Weight, Body) 01/2017 - 12/2016
2	Ulcerative Colitis 01/2017 - 01/2013
2	Memory Disorders (Memory Loss) 03/2013 - 03/2007
2	Gliosis 06/2011 - 03/2007
2	Birth Weight (Birth Weights) 01/2010 - 07/2005
2	Neuroblastoma 05/2003 - 10/2002
1	Fibrosis (Cirrhosis) 01/2023
1	Fatty Liver 01/2023
1	Alcoholic Fatty Liver 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Chronic Renal Insufficiency 01/2020
1	Hyperglycemia 01/2020
1	Obesity 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Atrophy 10/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2017
1	Schizophrenia (Dementia Praecox) 02/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Depressive Disorder (Melancholia) 05/2015
1	Ulcer 01/2013
1	Disease Progression 06/2011
1	Neuroinflammatory Diseases 10/2008
1	Premature Obstetric Labor (Premature Labor) 07/2005
1	Parkinson Disease (Parkinson's Disease) 06/2003
1	Ischemia 06/2003
1	Lewy Body Disease (Lewy Body Dementia) 05/2003

Drug/Important Bio-Agent (IBA)

8	(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamateIBA 10/2019 - 03/2002
6	indolineIBA 01/2023 - 05/2014
6	Cholinesterases (Cholinesterase)IBA 01/2013 - 10/2002
4	AN1284IBA 01/2023 - 10/2017
4	CarbamatesIBA 01/2017 - 05/2003
4	Cholinergic Agents (Cholinergics)IBA 01/2013 - 06/2003
4	Monoamine Oxidase (MAO)IBA 06/2011 - 04/2002
4	rasagiline (Azilect)FDA Link 05/2003 - 04/2002
3	CytokinesIBA 06/2023 - 06/2012
3	AntioxidantsIBA 10/2018 - 12/2012
3	Rivastigmine (Exelon)FDA LinkGeneric 01/2017 - 10/2008
3	2,4-dinitrofluorobenzene sulfonic acidIBA 12/2016 - 01/2013
2	3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateIBA 01/2024 - 06/2023
2	Dextrans (Dextran)FDA Link 01/2017 - 01/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 12/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 12/2016
2	Sulfonic AcidsIBA 12/2016 - 01/2013
2	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2013 - 01/2013
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2012 - 10/2008
2	Hormones (Hormone)IBA 01/2010 - 07/2005
2	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 03/2007 - 06/2003
2	(N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl methyl carbamateIBA 05/2003 - 10/2002
2	Amyloid (Amyloid Fibrils)IBA 05/2003 - 10/2002
2	methyl carbamateIBA 05/2003 - 10/2002
2	N-propargylIBA 05/2003 - 04/2002
2	Proteins (Proteins, Gene)FDA Link 05/2003 - 10/2002
1	Early Growth Response Protein 1IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	LipidsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2023
1	CreatinineIBA 01/2020
1	AlbuminsIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 10/2019
1	GalactosamineIBA 10/2017
1	LipopolysaccharidesIBA 10/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	SolutionsIBA 01/2017
1	2,4-dinitrobenzeneIBA 12/2016
1	Benzene (Benzole)IBA 12/2016
1	Corticotropin-Releasing HormoneIBA 05/2015
1	furanIBA 01/2015
1	cyclopentenoneIBA 01/2015
1	Organophosphonates (Phosphonates)IBA 01/2015
1	EstersIBA 05/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2013
1	SodiumIBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2012
1	AcetylcholinesteraseIBA 06/2011
1	ButyrylcholinesteraseIBA 06/2011
1	Streptozocin (Streptozotocin)FDA Link 03/2007
1	3-nitrotyrosineIBA 03/2007
1	Methionine EnkephalinIBA 07/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2005
1	propargylamineIBA 06/2003
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2003
1	phenethylamineIBA 11/2002

Therapy/Procedure

1	Injections 01/2023
1	Rectal Administration 01/2013
1	Immunomodulation 10/2008
1	Oral Administration 03/2007